<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04280757</url>
  </required_header>
  <id_info>
    <org_study_id>Elbanna_2020_02</org_study_id>
    <nct_id>NCT04280757</nct_id>
  </id_info>
  <brief_title>Comparison Between Biopsied and Non-biopsied Intracytoplasmatic Sperm Injection (ICSI) Embryos and Natural Pregnancy Embryos</brief_title>
  <acronym>BNB-ICSI</acronym>
  <official_title>Ambispective Comparative Cohort Study to Assess the Differences in Development and Growth Patterns of Biopsied and Non-Biopsied ICSI Embryos and Natural Pregnancy Embryos[BNB-ICSI Study]</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wael Elbanna Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fetal Medicine Research Center, Spain</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Wael Elbanna Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      As Pre Implantation Genetic Screening (PGS) becomes now a replacement modality and trend&#xD;
      gaining popularity among physicians and patients on claiming its ability to settle on the&#xD;
      simplest genetically normal embryo, so it had been logical to review if taking cells from the&#xD;
      embryo in its early development will or won't affect its growth as compared to the previous&#xD;
      standard technique of ICSI and in comparison to a normally conceived embryos the study also&#xD;
      will question if the parameters of the prenatal biochemical standard parameters will have any&#xD;
      differences if the embryo is already genetically tested embryo and compare these parameters&#xD;
      with non PGS embryos and normally conceived embryos.&#xD;
&#xD;
      This study is an ambispective, comparative, cohort, observational, single-center study.&#xD;
&#xD;
      The study participants' relevant medical records will be collected and reviewed for the&#xD;
      retrospective subjects and after obtaining informed consent for the prospective subjects. The&#xD;
      study materials that will be used will include blood tests and ultrasound. The study will&#xD;
      involve three study arms&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is an ambispective, comparative, cohort, observational, single-center study that&#xD;
      will be conducted at Wael ElBanna Clinic, a private center that is well equipped for all&#xD;
      procedures needed for ICSI and fetal medicine. After obtaining informed consent, the study&#xD;
      participants' relevant medical records will be collected and reviewed. Data will be collected&#xD;
      from the subjects' medical records. Data will be pooled and presented in aggregate, without&#xD;
      identification of individual subjects.&#xD;
&#xD;
      The study materials that will be used will include blood tests and ultrasound. The study will&#xD;
      involve three study arms:&#xD;
&#xD;
        -  Arm 1: biopsied ICSI embryos (PGS)&#xD;
&#xD;
        -  Arm 2: none biopsied ICSI embryos&#xD;
&#xD;
        -  Arm 3: natural pregnancy embryos&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 1, 2021</start_date>
  <completion_date type="Anticipated">May 2023</completion_date>
  <primary_completion_date type="Anticipated">April 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>First primary endpoint</measure>
    <time_frame>At pregnancy</time_frame>
    <description>- Early ultrasound measurements &quot;yolk sac (YS), mean sac diameter (MSD), crown rump length (CRL)&quot;, different maternal serum prenatal screening markers for growth and aneuploidy between the three arms* of the study</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Second primary endpoint</measure>
    <time_frame>At 2nd trimester of pregnancy</time_frame>
    <description>- Second trimetric U/S measurements of fetal growth : U/S measurements of fetal growth using growth curves and measurement of FPI (fetal ponderal index) and fetal weight percentile</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Third primary endpoint</measure>
    <time_frame>At 3rd trimester of pregnancy</time_frame>
    <description>- Third-trimester U/S measurements of fetal growth : U/S measurements of fetal growth using growth curves and measurement of FPI (fetal ponderal index) and fetal weight percentile</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>First secondary endpoint</measure>
    <time_frame>At Labor</time_frame>
    <description>Miscarriage</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Second secondary endpoint</measure>
    <time_frame>At Labor</time_frame>
    <description>Live-birth weight</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Third secondary endpoint</measure>
    <time_frame>At Labor</time_frame>
    <description>Preterm labor</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">420</enrollment>
  <condition>Women Conceiving by: 1- ICSI-PGS 2- ICSI-non-PGS 3- Spontaneously Conceiving Women</condition>
  <arm_group>
    <arm_group_label>Arm 1</arm_group_label>
    <description>Biopsied ICSI embryos</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 2</arm_group_label>
    <description>Non biopsied ICSI embryos</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 3</arm_group_label>
    <description>Natural pregnancy embryos</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Biopsied ICSI embryos (PGS)</intervention_name>
    <description>Biopsied ICSI embryos (PGS)</description>
    <arm_group_label>Arm 1</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The study population include women conceiving by:&#xD;
&#xD;
          1. ICSI-PGS&#xD;
&#xD;
          2. ICSI-non-PGS&#xD;
&#xD;
          3. Spontaneously conceiving women&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Singleton pregnant women&#xD;
&#xD;
          2. Pregnancy confirmation by ultrasound at week 6 of gestation either by normal pregnancy&#xD;
             or ICSI (Biopsied and Non-Biopsied)&#xD;
&#xD;
          3. Between the age of 20 and 40 years.&#xD;
&#xD;
          4. Non-smokers.&#xD;
&#xD;
          5. BMI must be between 19 and 40&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Those with anti-phospholipid syndrome confirmed by serological tests&#xD;
&#xD;
          2. Those with any hematological and immunological disorders&#xD;
&#xD;
          3. Women with uterine abnormalities have not been corrected.&#xD;
&#xD;
          4. Women with systemic diseases that cannot be controlled or managed&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wael Elbanna, Specialist</last_name>
    <role>Study Director</role>
    <affiliation>Wael Elbanna Clinic</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Eduard Gratacos, Specialist</last_name>
    <role>Principal Investigator</role>
    <affiliation>fetal medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Manal El-Hinnawi, Resident</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wael Elbanna Clinic</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Eslam Fathy, Resident</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wael Elbanna Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>wael Elbanna, Specialist</last_name>
    <phone>00201227760402</phone>
    <email>waelelbanna@drwaelelbanna.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>wael Elbanna Clinic</name>
      <address>
        <city>Cairo</city>
        <zip>11865</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>wael Elbanna, specialist</last_name>
      <phone>00201227760402</phone>
      <email>waelelbanna@drwaelelbanna.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>February 10, 2020</study_first_submitted>
  <study_first_submitted_qc>February 20, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 21, 2020</study_first_posted>
  <last_update_submitted>August 13, 2021</last_update_submitted>
  <last_update_submitted_qc>August 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Wael Elbanna Clinic</investigator_affiliation>
    <investigator_full_name>Wael Elbanna</investigator_full_name>
    <investigator_title>European board fellow of obstetrics and gynecology</investigator_title>
  </responsible_party>
  <keyword>fetal growth</keyword>
  <keyword>biochemical parameters</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

